Advances in neuroimaging to support translational medicine in dementia
Open Access
- 10 February 2021
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 92 (3), 263-270
- https://doi.org/10.1136/jnnp-2019-322402
Abstract
Advances in neuroimaging are ideally placed to facilitate the translation from progress made in cellular genetics and molecular biology of neurodegeneration into improved diagnosis, prevention and treatment of dementia. New positron emission tomography (PET) ligands allow one to quantify neuropathology, inflammation and metabolism in vivo safely and reliably, to examine mechanisms of human disease and support clinical trials. Developments in MRI-based imaging and neurophysiology provide complementary quantitative assays of brain function and connectivity, for the direct testing of hypotheses of human pathophysiology. Advances in MRI are also improving the quantitative imaging of vascular risk and comorbidities. In combination with large datasets, open data and artificial intelligence analysis methods, new informatics-based approaches are set to enable accurate single-subject inferences for diagnosis, prediction and treatment that have the potential to deliver precision medicine for dementia. Here, we show, through the use of critically appraised worked examples, how neuroimaging can bridge the gaps between molecular biology, neural circuits and the dynamics of the core systems that underpin complex behaviours. We look beyond traditional structural imaging used routinely in clinical care, to include ultrahigh field MRI (7T MRI), magnetoencephalography and PET with novel ligands. We illustrate their potential as safe, robust and sufficiently scalable to be viable for experimental medicine studies and clinical trials. They are especially informative when combined in multimodal studies, with model-based analyses to test precisely defined hypotheses.Funding Information
- Wellcome Trust (103838, 201567/Z/16/Z)
- National Institute for Health Research (no grant / award number)
- Medical Research Council (SUAG051/G101400)
This publication has 64 references indexed in Scilit:
- Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's DiseasePLoS Computational Biology, 2012
- Predicting Regional Neurodegeneration from the Healthy Brain Functional ConnectomeNeuron, 2012
- A Network Diffusion Model of Disease Progression in DementiaNeuron, 2012
- Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to DegenerationNeuron, 2011
- Functional and Effective Connectivity: A ReviewBrain Connectivity, 2011
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of NeurodegenerationNeuron, 2010
- Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental DisordersAmerican Journal of Psychiatry, 2010
- How does nature program neuron types?Frontiers in Neuroscience, 2008
- Representational similarity analysis – connecting the branches of systems neuroscienceFrontiers in Systems Neuroscience, 2008
- Neurodegenerative TauopathiesAnnual Review of Neuroscience, 2001